Stay updated with breaking news from Focus Area. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced its intention to submit a planning application...
Astellas Pharma is submitting a planning application for the construction of a new drug production facility in Ireland.
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) has announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330m in Tralee, Co. Kerry. This investment by Astellas in Ireland will expand our capacity and capabilities for aseptic drug products, reinforce stable production
“It’s a second home to a lot of racing people. I don’t think the county realized what that place meant to so many people,” said Lin O’Neill of the Save Southside Speedway movement that has advocated for a return of car racing to the venue.
Dublin, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The "Net-Zero Energy Buildings (NZEBs): Global Strategic Business Report" report has been added to ...